Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease-Reference-Cited by-同舟云学术

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease

Published:2018-09 Issue:3 Volume:155 Page:687-695.e10
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Dulai Parambir S.,Boland Brigid S.,Singh Siddharth,Chaudrey Khadija,Koliani-Pace Jenna L.,Kochhar Gursimran,Parikh Malav P.,Shmidt Eugenia^ORCID,Hartke Justin,Chilukuri Prianka,Meserve Joseph^ORCID,Whitehead Diana,Hirten Robert,Winters Adam C.,Katta Leah G.,Peerani Farhad,Narula Neeraj^ORCID,Sultan Keith,Swaminath Arun^ORCID,Bohm Matthew,Lukin Dana^ORCID,Hudesman David^ORCID,Chang John T.,Rivera-Nieves Jesus,Jairath Vipul,Zou G.Y.,Feagan Brian G.,Shen Bo,Siegel Corey A.,Loftus Edward V.,Kane Sunanda,Sands Bruce E.,Colombel Jean-Frederic,Sandborn William J.,Lasch Karen,Cao Charlie

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference51 articles.

1. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;N Engl J Med,2013

2. Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population;Ha;Clin Gastroenterol Hepatol,2012

3. The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: results from the US VICTORY Consortium;Dulai;Am J Gastroenterol,2016

4. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease—a prospective multicenter observational study;Stallmach;Aliment Pharmacol Ther,2016

5. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed;Sands;Gastroenterology,2014

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina;Biomolecules and Biomedicine;2024-09-06

2. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti Integrins;The Korean Journal of Gastroenterology;2024-08-25

3. Biomarkers for Personalizing IBD Therapy: The Quest Continues;Clinical Gastroenterology and Hepatology;2024-07

4. Vedolizumab in the treatment of Crohn's disease: A promising therapeutic approach;Drug Development Research;2024-06

5. Diagnosis and management of inflammatory bowel disease;Journal of Evidence-Based Medicine;2024-06